(lp0
S'CorMedix Inc. Makes NYSE MKT Section 610 Public Announcement Yahoo Finance - Mar 24, 2017 BEDMINSTER, NJ / ACCESSWIRE / March 23, 2017 / CorMedix Inc. , a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory&nbsp;...'
p1
aS'CorMedix Inc. Reports Fourth Quarter and Full Year 2016 Financial Results and ... Yahoo Finance - Mar 17, 2017 BEDMINSTER, NJ / ACCESSWIRE / March 17, 2017 / CorMedix Inc. , a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory&nbsp;...CorMedix crushed after warning on cash - Seeking AlphaCORMEDIX INC.  Files An 8-K Results of Operations and Financial ... - Market Exclusive'
p2
aS'Latest Stocks: The CorMedix Inc.  Stake Increased by Franklin Resources Inc. Petro Global News 24 - 10 hours ago Franklin Resources Inc. raised its stake in CorMedix Inc.  by 13.2% during the fourth quarter, according to its most recent filing with the SEC.'
p3
aS'CorMedix Inc. CRMD  Wall Street Journal - Feb 11, 2011 News CorMedix Inc.CRMD. Significant News Only. 03/02/17; Press Release.  CorMedix Inc. Appoints John L.  Armstrong to Senior Leadership Team.'
p4
aS'What Happened to CorMedix Inc.  MicroCap Daily - Jul 29, 2015 CorMedix Inc.  recently saw a parabolic rise to highs of $10.40 a share off its base at just over $1. Since then the stock has been in steep decline heading back to where it started.'
p5
aS'CorMedix Inc. : Strong Sell On Partner Failure, -91.4% Downside: Pump ... ValueWalk - Jun 29, 2015 I believe CorMedix is one of the most brazen, worthless biotech shells of insider enrichment I have ever seen. Bankruptcy documents show Cormedix  is based on a 1970s-era catheter product acquired for &lt;$1m cash the last time this&nbsp;...CorMedix: Strong Sell On Partner Failure, Misleading Data And Paid Stock ... - Seeking Alpha'
p6
aS'Form 8-K CorMedix Inc. For: Jan 30 StreetInsider.com - Feb 1, 2017 His prior pharma experience includes: Executive Vice President and Chief Financial Officer at Strata Skin Sciences, Inc. from April 2014 to January 2016; Senior Vice President and Chief Financial Officer at Immune Pharmaceuticals, Inc. from August 2013 ...'
p7
aS'CorMedix Inc. Receives Positive Feedback from FDA for Neutrolin Clinical ... PR Newswire  - Jun 17, 2015 BEDMINSTER, N.J., June 17, 2015 /PRNewswire/ -- CorMedix Inc. , a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious disease,&nbsp;...CorMedix  Stock Gains After Receiving Positive FDA Feedback for Neutrolin - TheStreet.com'
p8
aS'Resonant Down 70% Could CorMedix Inc.  Be Next? ValueWalk - Apr 13, 2015 CorMedix has a market capitalization of $400 million, its stock is up 370% year to date, its trading at 2,000x 2014 revenue , it has a going concern, it needs to raise capital, it recently filed an equity offering, it faces significant ...'
p9
aS'CorMedix Inc Price Volatility Hits An Unsually High Level CML News - Mar 16, 2017 This is a proprietary realized volatility rating created by Capital Market Laboratories  based on a large number of data interactions for CorMedix Inc  . We examine the little used gem of daily stock volatility over a 20-day and 30 ...CorMedix, Inc.  Tumbles -22.22% in Pre-Market - Benchmark Monitor'
p10
a.